NucleoBio
Founded 2016
About NucleoBio
NucleoBio is the developer of diagnostics tools designed to detect non-invasive urological cancer. The company's diagnostics tools uses high-throughput genomic and proteomic profiling technologies via urinalysis assay, enabling physicians to detect new tumor development for prostate cancer.
Company Facts
- Founded: 2016
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Website: nucleobio.net
Canonical: https://fsome.com/organization/nucleobio-8372178 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.